OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging
Boqia Xie, Jiaxin Wang, Xiaoying Xi, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2786-2797
Open Access | Times Cited: 49
Boqia Xie, Jiaxin Wang, Xiaoying Xi, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2786-2797
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
FAPI PET/CT Imaging—An Updated Review
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2018-2018
Open Access | Times Cited: 50
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2018-2018
Open Access | Times Cited: 50
Non-oncologic incidental uptake on FAPI PET/CT imaging
Masatoshi Hotta, Angela C. Rieger, Mahbod G Jafarvand, et al.
British Journal of Radiology (2022) Vol. 96, Iss. 1142
Open Access | Times Cited: 60
Masatoshi Hotta, Angela C. Rieger, Mahbod G Jafarvand, et al.
British Journal of Radiology (2022) Vol. 96, Iss. 1142
Open Access | Times Cited: 60
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin, Xinxin Yin, Xin Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
Xiaoying Yin, Xinxin Yin, Xin Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 9
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 9
Myocardial Activity at 18F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Li Wang, Yilu Wang, Juan Wang, et al.
Radiology (2022) Vol. 306, Iss. 2
Closed Access | Times Cited: 38
Li Wang, Yilu Wang, Juan Wang, et al.
Radiology (2022) Vol. 306, Iss. 2
Closed Access | Times Cited: 38
Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis
Xuezhu Wang, Yubo Guo, Yajuan Gao, et al.
JACC. Cardiovascular imaging (2022) Vol. 15, Iss. 11, pp. 1960-1970
Open Access | Times Cited: 31
Xuezhu Wang, Yubo Guo, Yajuan Gao, et al.
JACC. Cardiovascular imaging (2022) Vol. 15, Iss. 11, pp. 1960-1970
Open Access | Times Cited: 31
[68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling
Min Zhang, Weiwei Quan, Tianqi Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 3, pp. 839-848
Open Access | Times Cited: 29
Min Zhang, Weiwei Quan, Tianqi Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 3, pp. 839-848
Open Access | Times Cited: 29
Current research topics in FAPI theranostics: a bibliometric analysis
Andor F. van den Hoven, Ruth G.M. Keijsers, Marnix G. E. H. Lam, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1014-1027
Closed Access | Times Cited: 29
Andor F. van den Hoven, Ruth G.M. Keijsers, Marnix G. E. H. Lam, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1014-1027
Closed Access | Times Cited: 29
Detection of myocardial fibrosis: Where we stand
Leyi Zhu, Yining Wang, Shihua Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Leyi Zhu, Yining Wang, Shihua Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging
Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1786-1792
Open Access | Times Cited: 20
Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1786-1792
Open Access | Times Cited: 20
The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remodeling and Injury
Maday Fernández‐Mayola, James T. Thackeray
Current Cardiology Reports (2023) Vol. 25, Iss. 6, pp. 515-523
Open Access | Times Cited: 13
Maday Fernández‐Mayola, James T. Thackeray
Current Cardiology Reports (2023) Vol. 25, Iss. 6, pp. 515-523
Open Access | Times Cited: 13
Molecular Imaging of Heart Failure: An Update and Future Trends
Antti Saraste, Mia Ståhle, Anne Roivainen, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 5, pp. 674-685
Open Access | Times Cited: 4
Antti Saraste, Mia Ståhle, Anne Roivainen, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 5, pp. 674-685
Open Access | Times Cited: 4
99mTc-HFAPi SPECT Imaging Predicts Left Ventricular Remodeling After Acute Myocardial Infarction
Cuncun Hua, Xiaoying Xi, Yeping Zhang, et al.
Journal of Nuclear Cardiology (2024) Vol. 38, pp. 101910-101910
Closed Access | Times Cited: 4
Cuncun Hua, Xiaoying Xi, Yeping Zhang, et al.
Journal of Nuclear Cardiology (2024) Vol. 38, pp. 101910-101910
Closed Access | Times Cited: 4
Cardiovascular PET imaging of fibroblast activation A review of the current literature
Krithika Loganath, Neil J Craig, Anna Barton, et al.
Journal of Nuclear Cardiology (2024), pp. 102106-102106
Open Access | Times Cited: 4
Krithika Loganath, Neil J Craig, Anna Barton, et al.
Journal of Nuclear Cardiology (2024), pp. 102106-102106
Open Access | Times Cited: 4
Imaging Fibroblast Activation Protein
Stephanie Thorn, Francis G. Spinale, Albert J. Sinusas
Journal of the American College of Cardiology (2025)
Closed Access
Stephanie Thorn, Francis G. Spinale, Albert J. Sinusas
Journal of the American College of Cardiology (2025)
Closed Access
PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis
Patrícia Marques‐Alves, Lino Gonçalves, Maria João Ferreira
Diagnostics (2025) Vol. 15, Iss. 2, pp. 133-133
Open Access
Patrícia Marques‐Alves, Lino Gonçalves, Maria João Ferreira
Diagnostics (2025) Vol. 15, Iss. 2, pp. 133-133
Open Access
Molecular imaging of cardiovascular disease: Current status and future perspective
Takehiro Nakahara, Shinichiro Fujimoto, Masahiro Jinzaki
Journal of Cardiology (2025)
Closed Access
Takehiro Nakahara, Shinichiro Fujimoto, Masahiro Jinzaki
Journal of Cardiology (2025)
Closed Access
Comparison of the value of FAPI imaging and speckle‑tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension
Bi-Xi Chen, Huimin Hu, Juanni Gong, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Bi-Xi Chen, Huimin Hu, Juanni Gong, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease
Matthieu Bailly, A.C. Dupont, Guillaume Domain, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 387-387
Open Access
Matthieu Bailly, A.C. Dupont, Guillaume Domain, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 387-387
Open Access
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
William Serumula, Venesen Pillay, Bawinile Hadebe, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 522-522
Open Access
William Serumula, Venesen Pillay, Bawinile Hadebe, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 522-522
Open Access
Application of 68Ga‐ and 177Lu‐Labeled FAP Inhibitor in Evaluation and Treatment of Cardiac Fibrosis After Myocardial Infarction
Yiheng Zhao, Xiangyu Su, Boyang Xiang, et al.
MedComm (2025) Vol. 6, Iss. 6
Open Access
Yiheng Zhao, Xiangyu Su, Boyang Xiang, et al.
MedComm (2025) Vol. 6, Iss. 6
Open Access
Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga]Ga-FAPI-04 PET/CMR imaging
Jie Ding, Hang Zhang, Xing Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 52, Iss. 1, pp. 98-108
Closed Access | Times Cited: 3
Jie Ding, Hang Zhang, Xing Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 52, Iss. 1, pp. 98-108
Closed Access | Times Cited: 3
A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al18F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
Zhehao Lyu, Wei Han, Hongyue Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Zhehao Lyu, Wei Han, Hongyue Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Displays of 18F-FAPI PET/CT in Myocarditis With Variable Symptom Durations
Weicheng Zhou, Jinju Sun, Fangyang Wang, et al.
Clinical Nuclear Medicine (2023) Vol. 48, Iss. 9, pp. 799-801
Closed Access | Times Cited: 7
Weicheng Zhou, Jinju Sun, Fangyang Wang, et al.
Clinical Nuclear Medicine (2023) Vol. 48, Iss. 9, pp. 799-801
Closed Access | Times Cited: 7
99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heart
Boqia Xie, Lina Li, Mingming Lin, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 10, pp. 1645-1652
Closed Access | Times Cited: 7
Boqia Xie, Lina Li, Mingming Lin, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 10, pp. 1645-1652
Closed Access | Times Cited: 7
